Latest placebo Stories
WASHINGTON, April 14, 2015 /PRNewswire-USNewswire/ -- A new study suggests that an investigational drug for multiple sclerosis (MS) may repair myelin, the fatty material that protects nerves
LEXINGTON, Massachusetts, April 9, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the 13-week Phase 2 IMAGO trial of its investigational compound
TOKYO and SAN FRANCISCO, April 2, 2015 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) and Medivation, Inc.
The Study did not achieve its primary efficacy endpoint PETACH TIKVA, Israel, March 30, 2015 /PRNewswire/ -- Can-Fite
COSTA MESA, Calif., March 20, 2015 /PRNewswire-iReach/ -- WCCT Global, a contract research organization headquartered in Orange County, CA, successfully completed a Phase 2 ophthalmology
NORTHBROOK, Ill. and SAN FRANCISCO, March 16, 2015 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc.
Randomized, Blinded, Placebo-Controlled Phase 2 Study Meets Its Primary Endpoint. SAN FRANCISCO, March 16, 2015 /PRNewswire/ -- Kindred Biosciences, Inc.
SAP301 Trial to Study Sufentanil Sublingual Single-Dose Tablet for the Treatment of Moderate-to-Severe Acute Pain REDWOOD CITY, Calif., March 16, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals,
SAN DIEGO, March 7, 2015 /PRNewswire/ -- Today, new data from the phase 3a SCALE(TM) Obesity and Pre-diabetes trial were presented at The Endocrine Society's 97(th) Annual Meeting (ENDO), showing that
MISSISSAUGA, ON, March 5, 2015 /PRNewswire/ - Nuvo Research Inc.